| Clinical Trial Press Releases Topics Locations Industries Dates
By IVIEW Therapeutics Inc. IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.
| ![12973824](data:image/jpeg;base64,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) | By Wei Wang, PhD IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts and clinicians to gain key insights on dry eye treatment innovations.
|
Page updated every 10 minutes
| |